Cristiana A. Costa, DO

Assistant Professor of Medicine
Campus mail 2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
Phone (919) 668-1000
Email address

Education and Training

  • Hematology/Oncology Fellowship, Dartmouth College, Geisel School of Medicine, 2014 - 2017
  • Pennsylvania Hospital, University of Pennsylvania, School of Medicine, 2011 - 2014
  • D.O., Philadelphia College of Osteopathic Medicine, 2011


Lansigan, Frederick, Cristiana A. Costa, Bassem I. Zaki, Stephanie P. Yen, Eric S. Winer, Helen Ryan, Darcie Findley, et al. “Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe).” Clin Cancer Res 25, no. 20 (October 15, 2019): 6073–79.

Full Text

Epperla, Narendranath, Kami J. Maddocks, Mohammed Salhab, Julio C. Chavez, Nishitha Reddy, Reem Karmali, Elvira Umyarova, et al. “C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional “hits” and outcomes with subsequent therapy.” Cancer 123, no. 22 (November 15, 2017): 4411–18.

Full Text

Landsburg, Daniel J., Marissa K. Falkiewicz, Joseph Maly, Kristie A. Blum, Christina Howlett, Tatyana Feldman, Anthony R. Mato, et al. “Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.” Journal of Clinical Oncology 35, no. 20 (July 10, 2017): 2260–67.

Full Text

Costa, Luciano J., Kami Maddocks, Narendranath Epperla, Nishitha M. Reddy, Reem Karmali, Elvira Umyarova, Veronika Bachanova, et al. “Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.” American Journal of Hematology 92, no. 2 (February 2017): e24615–e24615.

Full Text

Costa, Cristiana A., Bassem I. Zaki, Stephanie P. Yen, Eric S. Winer, Helen Ryan, Darcie Findley, Sara R. Metzler, et al. “Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival.” In Blood, 128:1793–1793. American Society of Hematology, 2016.

Full Text